安图生物：“白介素4检测试剂盒”等产品取得注册证

Core Viewpoint - Antu Biology has received a medical device registration certificate from the Henan Provincial Drug Administration for products including the "Interleukin-4 Test Kit" [1] Company Summary - Antu Biology's revenue composition for the year 2024 is projected to be 98.17% from in vitro diagnostics and 1.83% from other businesses [1] - As of the report, Antu Biology has a market capitalization of 21 billion yuan [1]